Interpace Biosciences, Inc.
IDXGD
$6.98
-$0.02-0.29%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 24.45M | 23.65M | 24.58M | 3.80M | 4.56M |
| Total Depreciation and Amortization | 893.00K | 856.00K | 821.00K | 811.00K | 789.00K |
| Total Amortization of Deferred Charges | 32.00K | 47.00K | 58.00K | 42.00K | 26.00K |
| Total Other Non-Cash Items | -20.55M | -20.62M | -20.91M | 565.00K | 947.00K |
| Change in Net Operating Assets | -364.00K | 947.00K | 1.29M | -340.00K | -1.27M |
| Cash from Operations | 4.46M | 4.88M | 5.83M | 4.88M | 5.06M |
| Capital Expenditure | -353.00K | -497.00K | -356.00K | -447.00K | -852.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -353.00K | -497.00K | -356.00K | -447.00K | -852.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.90M | -2.90M | -4.40M | -4.90M | -5.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18.00K | -18.00K | -18.00K | -46.00K | -46.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -13.00K | -13.00K | -174.00K | -174.00K |
| Cash from Financing | -1.92M | -2.93M | -4.43M | -5.12M | -5.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.19M | 1.45M | 1.04M | -690.00K | -1.52M |